Jaakko Valtola

Savonlinna, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation.

Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 23, 2023

Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.

Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.

Journal: Journal of clinical apheresis

Published: July 08, 2022

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma.

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma.

Journal: Journal of hematology

Published: October 21, 2021

Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.

Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.

Journal: Transfusion

Published: December 07, 2020

Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.

Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.

Journal: Transfusion

Published: August 25, 2020

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival.

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival.

Journal: Leukemia & lymphoma

Published: July 14, 2020

Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study.

Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study.

Journal: Leukemia & lymphoma

Published: May 19, 2020

CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.

CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.

Journal: Transfusion

Published: January 03, 2020

A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients.

A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients.

Journal: Journal of clinical apheresis

Published: November 21, 2019

Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients.

Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients.

Journal: Leukemia & lymphoma

Published: March 08, 2019

Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.

Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.

Journal: Leukemia & lymphoma

Published: August 31, 2018

Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients.

Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients.

Journal: Transfusion

Published: June 01, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026